Notably, ERBB3 expression showed no significant differences across pathological stages (Figure 7(B)), which closely mirrored the abundance dynamics of S. flexneri C.11 during CRC progression (Figure S6(A)). This evidence concerns the gene ERBB3 and colorectal carcinoma.